|
MedChemExpress
janex 1 Janex 1, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/janex 1/product/MedChemExpress Average 91 stars, based on 1 article reviews
janex 1 - by Bioz Stars,
2026-02
91/100 stars
|
Buy from Supplier |
|
Santa Cruz Biotechnology
inhibitor janex Inhibitor Janex, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/inhibitor janex/product/Santa Cruz Biotechnology Average 93 stars, based on 1 article reviews
inhibitor janex - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
Selleck Chemicals
jak3 inhibitor janex 1 ![]() Jak3 Inhibitor Janex 1, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/jak3 inhibitor janex 1/product/Selleck Chemicals Average 93 stars, based on 1 article reviews
jak3 inhibitor janex 1 - by Bioz Stars,
2026-02
93/100 stars
|
Buy from Supplier |
|
Cayman Chemical
jak3 inhibitor janex-1 ![]() Jak3 Inhibitor Janex 1, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/jak3 inhibitor janex-1/product/Cayman Chemical Average 90 stars, based on 1 article reviews
jak3 inhibitor janex-1 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Cayman Chemical
whi-p131 (4-[(6,7-dimethoxy-4-quinazolinyl) amino]-phenol; janex-1 ![]() Whi P131 (4 [(6,7 Dimethoxy 4 Quinazolinyl) Amino] Phenol; Janex 1, supplied by Cayman Chemical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/whi-p131 (4-[(6,7-dimethoxy-4-quinazolinyl) amino]-phenol; janex-1/product/Cayman Chemical Average 90 stars, based on 1 article reviews
whi-p131 (4-[(6,7-dimethoxy-4-quinazolinyl) amino]-phenol; janex-1 - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
GraphPad Software Inc
janex-1-m ![]() Janex 1 M, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/janex-1-m/product/GraphPad Software Inc Average 90 stars, based on 1 article reviews
janex-1-m - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
|
Taconic Biosciences
janex-1 treatment nod mice ![]() Janex 1 Treatment Nod Mice, supplied by Taconic Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/janex-1 treatment nod mice/product/Taconic Biosciences Average 90 stars, based on 1 article reviews
janex-1 treatment nod mice - by Bioz Stars,
2026-02
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Journal of Cell Communication and Signaling
Article Title: JAK3/STAT5 signaling‐triggered upregulation of PIK3CD contributes to gastric carcinoma development
doi: 10.1002/ccs3.12017
Figure Lengend Snippet: PIK3CD was positively regulated by JAK3/STAT5 signaling. (A) Heat maps of top 50 genes positively correlated with PIK3CD expression in STAD cohort of TCGA by LinkedOmics online tools. STAD, stomach adenocarcinoma. (B) The expression of PIK3CD was positively associated with JAK3, STAT5A and STAT5B in TCGA by Pearson correlation analysis. (C) The potential binding site of STAT5 in the promoter of PIK3CD. The four red nucleotides were mutated from wild‐type binding sites for construction of dual luciferase reporter plasmid (MUT). (D) The relative activities of PIK3CD promoter were examined by dual luciferase reporter kit in GC cells with STAT5A overexpression. * p < 0.05, ** p < 0.01. (E) The protein expression was tested by western blotting upon STAT5A overexpression in MGC803 and AGS cells. (F) Cells were treated with human IL‐2, JANEX‐1 and STAT5 inhibitor (SH‐4‐54) as indicated concentrations. PIK3CD expression was examined by western blot analysis. JANEX‐1, JAK3 inhibitor.
Article Snippet: PI3Kδ inhibitors, including Acalisib (#S5818), compound 7n (#S8693) and Idelalisib (#S2226), STAT3/STAT5 inhibitor SH‐4‐54 (#S7337), STAT3 inhibitor BP‐1‐102 (#S7769), and
Techniques: Expressing, Binding Assay, Luciferase, Plasmid Preparation, Over Expression, Western Blot
Journal: Journal of Cell Communication and Signaling
Article Title: JAK3/STAT5 signaling‐triggered upregulation of PIK3CD contributes to gastric carcinoma development
doi: 10.1002/ccs3.12017
Figure Lengend Snippet: The correlations between PI3K subunits, JAK3 and immune cell infiltration in GC. (A) PIK3CA and immune cell infiltration. The correlation analysis between each gene with immune cell infiltration was performed via TIMER algorithm. (B) PIK3CB and immune cell infiltration. The correlation analysis between each gene with immune cell infiltration was performed via TIMER algorithm. (C) PIK3CD and immune cell infiltration. The correlation analysis between each gene with immune cell infiltration was performed via TIMER algorithm. (D) JAK3 and immune cell infiltration. The correlation analysis between each gene with immune cell infiltration was performed via TIMER algorithm. (E) Pro‐inflammatory lymphocyte and LPS had significant impact on PIK3CD expression, but not for PIK3CA and PIK3CB. (F) The effect of overexpression of STAT5 on protein expression of PIK3CA, PIK3CB and PIK3CD. (G) The effect of JANEX‐1 and STAT5 inhibitor (SH‐45‐4) on protein expression of PIK3CA, PIK3CB and PIK3CD. GC, gastric cancer; JANEX‐1, JAK3 inhibitor; LPS, lipopolysaccharide.
Article Snippet: PI3Kδ inhibitors, including Acalisib (#S5818), compound 7n (#S8693) and Idelalisib (#S2226), STAT3/STAT5 inhibitor SH‐4‐54 (#S7337), STAT3 inhibitor BP‐1‐102 (#S7769), and
Techniques: Expressing, Over Expression